Moderna shares MRNA plunged on Thursday after partial data from its closely watched cancer vaccine trial leaked ahead of a scheduled presentation at the European Society for Medical Oncology conference, triggering a sharp sell-off despite
US stocks fell on Thursday as renewed concerns about artificial intelligence spending pressured technology shares, while rising geopolitical tensions in the Middle East pushed oil prices to a five-month high. The Nasdaq Composite recorded its
Special Agent Lili Infante was determined to shatter every stereotype held by her colleagues at the Drug Enforcement Administration. As an Ivy League graduate, a Russian immigrant, and the sole woman in her academy class,
A woman in Johnston County discovered the devastating speed of digital theft when her entire life savings vanished in a matter of seconds. Believing she was speaking with law enforcement officers who demanded payment for
Tesla (TSLA) stock has recovered rather significantly in recent months, but the derivatives market believes that momentum will only accelerate after the company reports earnings on October 21st.Consensus estimates for the EV maker’s profit and
Strategy (MSTR) stock has traded within a narrow range over the past few days as Bitcoin's rally has lost momentum. The stock was trading at $142.70, down from its September high of $170. However, this
Moving digital assets has long been a tedious process defined by the anxiety of copying lengthy alphanumeric strings and selecting the correct blockchain networks. To solve this, crypto infrastructure provider Zerohash has unveiled AUTH, a
In a strange turn of events where the tool became the detective, a software developer discovered their computer had been hijacked by a cryptocurrency miner thanks to an unexpected alert from an AI coding assistant.
The artificial intelligence trade has faced several headwinds this year, but last week's sell-off struck at the foundations of the multiyear AI infrastructure boom, revealing a stark shift in investor sentiment as warnings about financing
Anthropic's potential initial public offering is facing an early test of investor appetite, with some prospective and existing investors reportedly considering a valuation of around $1.5 trillion, below the roughly $2 trillion target previously expected
